Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathomechanisms in celiac disease.

Walburga Dieterich1, Birgit Esslinger, Detlef Schuppan

  • 1Medical Department I, University of Erlangen-Nürnberg, Erlangen, Germany.

International Archives of Allergy and Immunology
|November 6, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Vitro TLR4 Stimulating Bioactivities of Amylase/Trypsin-Inhibitors from Wheat (<i>Triticum aestivum</i> L.) Bred from 1891 to 2010.

Foods (Basel, Switzerland)·2026
Same author

Erratum to 'Hot and cold fibrosis: The role of serum biomarkers to assess immune mechanisms and ECM-cell interactions in human fibrosis' [J Hepatol 83 (2025) 239-257].

Journal of hepatology·2026
Same author

Upcoming Treatments in Celiac Disease: From Luminal Enzymes to Oral Immune Tolerance.

United European gastroenterology journal·2026
Same author

Therapeutic TG2 inhibition reverses systemic multiomic dysregulation in celiac disease.

BMC medicine·2026
Same author

Sex-related differences in cardiovascular inflammation and metabolomics in a humanized transgenic mouse model of celiac disease.

Scientific reports·2026
Same author

ECM1 produced by hepatic stellate cells serves as a gatekeeper of liver homeostasis in hepatic fibrosis.

Hepatology (Baltimore, Md.)·2026

Celiac disease involves genetic factors, gluten, and tissue transglutaminase (tTG). Modified gluten peptides, enhanced by tTG, trigger T cell responses, driving the autoimmune condition and mucosal damage.

Area of Science:

  • Immunology
  • Gastroenterology
  • Genetics

Background:

  • Celiac disease (CD) is an autoimmune disorder with strong genetic links (HLA-DQ2/DQ8).
  • Gluten acts as the primary etiological factor, triggering an immune response.
  • Tissue transglutaminase (tTG) is a key autoantigen, with IgA autoantibodies to tTG being highly predictive.

Purpose of the Study:

  • To elucidate the role of tissue transglutaminase (tTG) in celiac disease pathogenesis.
  • To understand how gluten peptides interact with HLA-DQ2/DQ8 molecules.
  • To explore novel therapeutic strategies targeting celiac disease mechanisms.

Main Methods:

  • Analysis of genetic associations (HLA-DQ2/DQ8).
  • Investigation of gluten peptide modification by tTG (deamidation).

Related Experiment Videos

  • Study of immune responses in the lamina propria.

    • Main Results:

    • tTG modification, particularly deamidation, enhances gluten peptide binding to HLA-DQ2/DQ8.
    • This enhanced binding potentiates gluten-specific T cell stimulation.
    • tTG-catalyzed cross-linking facilitates gluten storage and prolonged availability in the mucosa.

    Conclusions:

    • Increased intestinal tTG expression is crucial for celiac disease pathogenesis.
    • tTG plays a dual role: modifying gluten for immune recognition and prolonging its mucosal presence.
    • Therapeutic strategies targeting tTG, gluten peptides, or HLA-DQ2/DQ8 are promising.